News & Investors
02. October 2019 - 11:40 (CEST)
Epigenomics AG: Results from Microsimulation Model to be presented at renowned health conference
Read more07. August 2019 - 8:11 (CEST)
Epigenomics AG Highlights Operational Achievements and Reports Financial Results for First Six Months 2019
Read more24. July 2019 - 17:06 (CEST)
Study Published in American Health Drug Benefits Suggests that Non-Invasive Screening Methods, Including Epi proColon®, Could Be A Cost-Effective Option To Help Achieve Target U.S. Colorectal Cancer Screening Rates
Read more15. July 2019 - 15:49 (CEST)
Chinese Patent Reexamination Department partially invalidates Epigenomics’ patent claims for Septin9
Read more11. July 2019 - 14:29 (CEST)
